NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Integra Therapeutics

Integra Therapeutics

Private
BarcelonaHealthcare & Life Scienceshttps://integra-tx.com/

Last Round

VC Round

Sep 8, 2025

Total Funding Raised

$16.14M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Integra Therapeutics is a biotechnology company that creates next-generation gene writing tools to improve the safety and efficacy of advanced therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

gene writingFiCATgene therapyCRISPRcell engineeringtransposasegenome editingCAR-Tprotein engineeringbiotechsynthetic biologydrug discoveryDNA insertionprotein designgene editing tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Integra Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Integra Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Integra Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 8, 2025
GrantJul 17, 2024
SeedMar 30, 2022
SeedDec 2, 2021

Key People

Founding team and executive leadership

Avencia Sanchez-Mejias

CEO And Co-founder

Founding Team

Integra Therapeutics Investors

Notable investors and investment history

Integra Therapeutics investors
InvestorRounds
European Innovation Council FundGrant
CDTI InnvierteVC Round
Pompeu Fabra UniversityVC Round, Seed
Center for Technological Development and InnovationVC Round
Takeda VenturesVC Round, Seed
Invivo PartnersVC Round, Seed
Columbus Venture PartnersSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 32% MoM, reaching 3.5K.

  • May 16, 2026

    Monthly visitors increased 93% MoM.

Integra Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Integra Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Integra Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range23
Year Founded2020
Last FundingSep 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.